These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27131768)

  • 1. CHA2DS2-Vasc score, age and body mass index as the main risk factors of hyperintense brain lesions in asymptomatic patients with paroxysmal non-valvular atrial fibrillation.
    Wieczorek J; Mizia-Stec K; Lasek-Bal A; Wieczorek P; Hoffmann A; Nowak S; Kolasa J; Faryan M; Woźniak-Skowerska I; Wnuk-Wojnar A
    Int J Cardiol; 2016 Jul; 215():476-81. PubMed ID: 27131768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial fibrillation is associated with anterior predominant white matter lesions in patients presenting with embolic stroke.
    Mayasi Y; Helenius J; McManus DD; Goddeau RP; Jun-O'Connell AH; Moonis M; Henninger N
    J Neurol Neurosurg Psychiatry; 2018 Jan; 89(1):6-13. PubMed ID: 28554961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperintense Brain Lesions in Asymptomatic Low Risk Patients with Paroxysmal Atrial Fibrillation Undergoing Radiofrequency Pulmonary Vein Isolation.
    Wieczorek J; Mizia-Stec K; Lasek-Bal A; Wieczorek P; Woźniak-Skowerska I; Wnuk-Wojnar AM; Szydło K
    J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33546182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation.
    Letsas KP; Efremidis M; Giannopoulos G; Deftereos S; Lioni L; Korantzopoulos P; Vlachos K; Xydonas S; Kossyvakis C; Sideris A
    Europace; 2014 Feb; 16(2):202-7. PubMed ID: 23813452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-admission CHADS2, CHA2DS2-VASc, and R2CHADS2 Scores on Severity and Functional Outcome in Acute Ischemic Stroke with Atrial Fibrillation.
    Tanaka K; Yamada T; Torii T; Furuta K; Matsumoto S; Yoshimura T; Takase K; Wakata Y; Nakashima N; Kira J; Murai H
    J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1629-35. PubMed ID: 25906940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
    Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM
    Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
    Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
    Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
    Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Piorkowski C; Gaspar T; Lip GY; Bollmann A
    Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHADS
    Wu JT; Wang SL; Chu YJ; Long DY; Dong JZ; Fan XW; Yang HT; Duan HY; Yan LJ; Qian P
    J Atheroscler Thromb; 2017 Feb; 24(2):176-184. PubMed ID: 27301462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of MRI-detected brain lesions and neurocognitive function after electrical cardioversion in anticoagulated patients with persistent atrial fibrillation.
    Bellmann B; Fiebach JB; Guttmann S; Lin T; Haeusler KG; Bathe-Peters R; Koehler L; Steffens D; Kasner M; Tscholl V; Nagel P; Roser M; Landmesser U; Rillig A
    Int J Cardiol; 2017 Sep; 243():239-243. PubMed ID: 28592382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of CHADS2 and CHA2DS2-VASc scoring systems for predicting postoperative atrial fibrillation after cardiac surgery.
    Chua SK; Shyu KG; Lu MJ; Lien LM; Lin CH; Chao HH; Lo HM
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):919-926.e1. PubMed ID: 23628495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CHADS2 and CHA2DS2-VASc scores predict adverse vascular function, ischemic stroke and cardiovascular death in high-risk patients without atrial fibrillation: role of incorporating PR prolongation.
    Chan YH; Yiu KH; Lau KK; Yiu YF; Li SW; Lam TH; Lau CP; Siu CW; Tse HF
    Atherosclerosis; 2014 Dec; 237(2):504-13. PubMed ID: 25463082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk and prediction of dementia in patients with atrial fibrillation--a nationwide population-based cohort study.
    Liao JN; Chao TF; Liu CJ; Wang KL; Chen SJ; Tuan TC; Lin YJ; Chang SL; Lo LW; Hu YF; Chung FP; Tsao HM; Chen TJ; Lip GY; Chen SA
    Int J Cardiol; 2015 Nov; 199():25-30. PubMed ID: 26173170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.
    Olesen JB; Torp-Pedersen C; Hansen ML; Lip GY
    Thromb Haemost; 2012 Jun; 107(6):1172-9. PubMed ID: 22473219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of stroke or TIA in patients without atrial fibrillation using CHADS2 and CHA2DS2-VASc scores.
    Mitchell LB; Southern DA; Galbraith D; Ghali WA; Knudtson M; Wilton SB;
    Heart; 2014 Oct; 100(19):1524-30. PubMed ID: 24860007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis.
    Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Liao JN; Chen TJ; Lip GY; Chen SA
    Heart Rhythm; 2014 Oct; 11(10):1752-9. PubMed ID: 24952148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
    Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
    JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparisons of CHADS2 and CHA2DS2-VASc scores for stroke risk stratification in atrial fibrillation: Which scoring system should be used for Asians?
    Chao TF; Liu CJ; Tuan TC; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Chen TJ; Chiang CE; Chen SA
    Heart Rhythm; 2016 Jan; 13(1):46-53. PubMed ID: 26277496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CHADS₂, CHA₂S₂DS₂-VASc, and long-term stroke outcome in patients without atrial fibrillation.
    Ntaios G; Lip GY; Makaritsis K; Papavasileiou V; Vemmou A; Koroboki E; Savvari P; Manios E; Milionis H; Vemmos K
    Neurology; 2013 Mar; 80(11):1009-17. PubMed ID: 23408865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.